Canton Strategic出售生物科技子公司Gravitas转向聚焦金融数字化
Odaily Planet Daily News: Canton Strategic Holdings, a Nasdaq-listed company, announced the completion of the sale of its biotechnology research and development subsidiary, Gravitas Life Sciences. The buyer in this transaction is Gravitas Collective Corp. The sale was unanimously approved by the company's board of directors and officially closed on July 17, 2026.
This divestiture represents a key strategic transformation move for the company. Going forward, the company will focus on the Canton Network ecosystem, transforming into a digital financial services provider. It will prioritize asset tokenization and the implementation of financial digitalization, while continuing to improve its compliant financial infrastructure business. (PRNewswire)
